Key result
Hyponatraemic patients with impaired water excretion had significantly higher urinary excretion of AQP-2 (41.1 vs 21.7 fmol/micromol creatinine) compared to controls.
Why the study?
Is the hydro-osmotic action of arginine vasopressin (AVP), as measured by urinary excretion of AQP-2, exaggerated in hyponatremic patients with impaired water excretion?
Case-Control (n=30)
Is the hydro-osmotic action of arginine vasopressin (AVP), as measured by urinary excretion of AQP-2, exaggerated in hyponatremic patients with impaired water excretion?
Answers are grounded in this paper and cite their sources.
Hyponatremic patients with impaired water excretion exhibit exaggerated urinary excretion of AQP-2 relative to plasma AVP levels, indicating enhanced hydro-osmotic action of AVP.
OBJECTIVE: The present study was undertaken to determine whether the hydro-osmotic action of arginine vasopressin (AVP) is exaggerated in pathological states of impaired water excretion by measuring urinary excretion of the aquaporin-2 (AQP-2) water channel. PATIENTS AND MEASUREMENTS: Eighteen hyponatraemic patients with impaired water excretion and 12 control subjects were studied during an acute oral water load (20 ml/kg body weight). RESULTS: In the patient group plasma AVP levels were 1.6 pmol/l, relatively high compared to plasma osmolality of 279.8 mmol/kg. Urinary excretion of AQP-2 under ad libitum water drinking was 41.1 fmol/micromol creatinine in the patient group, a value significantly greater than that of 21.7 fmol/micromol creatinine in the control subjects. The acute water load verified the impairment in water excretion in the patient group, as the excretion of the water load was only 28.2% (control, 77.3%, P < 0.001) and the minimum urinary osmolality was as high as 437.3 mmol/kg (control, 122.9 mmol/kg, P < 0.001). Also, the minimum urinary excretion of AQP-2 was significantly greater in the patient group than that in the control. There was a positive correlation between plasma AVP levels and urinary excretion of AQP-2 in the control subjects (r = 0.56, P < 0.01). In contrast, the urinary excretion of AQP-2 was exaggerated compared to the respective plasma AVP levels in the patient group, and thus the positive correlation disappeared. CONCLUSION: These results indicate that hydroosmotic action of AVP is exaggerated more than that expected from plasma AVP levels in pathological states of impaired water excretion, with non-suppressible, but normal, arginine vasopressin levels in spite of the hypo-osmotic condition.
No takes yet. Share an insight, caveat, or question.
Saitô et al. (2001) conducted a case-control in Hyponatraemia with impaired water excretion (n=30). Impaired water excretion (hyponatraemia) vs. Control subjects was evaluated on Urinary excretion of AQP-2 under ad libitum water drinking. Hyponatraemic patients with impaired water excretion had significantly higher urinary excretion of AQP-2 (41.1 vs 21.7 fmol/micromol creatinine) compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: